Cargando…

Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study

BACKGROUND: Nutritional deficits, cachexia, and sarcopenia are extremely common in esophageal cancer. The aim of this article was to assess the effect of loss of skeletal muscle mass during neoadjuvant treatment on the prognosis of esophageal cancer patients. METHODS: Esophageal cancer patients (N =...

Descripción completa

Detalles Bibliográficos
Autores principales:	Järvinen, Tommi, Ilonen, Ilkka, Kauppi, Juha, Salo, Jarmo, Räsänen, Jari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809976/ https://www.ncbi.nlm.nih.gov/pubmed/29433514 http://dx.doi.org/10.1186/s12957-018-1327-4

Ejemplares similares

Low skeletal muscle mass in stented esophageal cancer predicts poor survival: A retrospective observational study
por: Järvinen, Tommi, et al.
Publicado: (2018)

Health-related quality of life after laparoscopic repair of giant paraesophageal hernia: how does recurrence in CT scan compare to clinical success?
por: Hietaniemi, Henriikka, et al.
Publicado: (2020)

General thoracic surgery in Finland, a perspective from the Helsinki University Hospital
por: Järvinen, Tommi, et al.
Publicado: (2022)

Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
por: Järvinen, Tommi, et al.
Publicado: (2021)

Patient features predicting long‐term survival and health‐related quality of life after radical surgery for non‐small cell lung cancer
por: Rauma, Ville, et al.
Publicado: (2016)

Hand-sewn versus stapled anastomoses for esophagectomy: We will probably never know which is better
por: Järvinen, Tommi, et al.
Publicado: (2021)

Increased Oxidative Stress in the Proximal Stomach of Patients with Barrett’s Esophagus and Adenocarcinoma of the Esophagus and Esophagogastric Junction()
por: Kauppi, Juha, et al.
Publicado: (2016)

Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery
por: Reisinger, Kostan W., et al.
Publicado: (2015)

Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma
por: Söderström, Henna K, et al.
Publicado: (2019)

Tracheal and laryngotracheal resections and reconstructions—a single-centre experience
por: Marchant, Felipe, et al.
Publicado: (2022)

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
por: Yoon, Han Gyul, et al.
Publicado: (2020)

Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients
por: Moon, Sung Woo, et al.
Publicado: (2019)

Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study
por: Salo, Silja A. S., et al.
Publicado: (2020)

Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer
por: Amitani, Masatsugu, et al.
Publicado: (2022)

Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland
por: Torkki, Paulus, et al.
Publicado: (2021)

Long-Term Health-Related Quality of Life (HRQoL) After Redo-Fundoplication
por: Kivelä, Antti J., et al.
Publicado: (2021)

Chemoradiation for oesophageal cancer: the choice of treatment modality
por: Kitti, Pauliina M., et al.
Publicado: (2023)

Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics
por: Molenaar‐Kuijsten, Laura, et al.
Publicado: (2021)

Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer
por: Lee, Byung Min, et al.
Publicado: (2021)

Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Imai, Kenji, et al.
Publicado: (2019)

Menopause and the Loss of Skeletal Muscle Mass in Women
por: KO, Jupil, et al.
Publicado: (2021)

Weight Loss Strategies and the Risk of Skeletal Muscle Mass Loss
por: McCarthy, David, et al.
Publicado: (2021)

Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis
por: Delou, João Marcos de Azevedo, et al.
Publicado: (2017)

Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy
por: Panje, Cédric M., et al.
Publicado: (2019)

Worse prognosis in young patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A comparative study
por: Zhang, Yiyi, et al.
Publicado: (2020)

CT‐determined low skeletal muscle mass predicts worse overall survival of gastric cancer in patients with cachexia
por: Wan, Qianyi, et al.
Publicado: (2022)

Skeletal Muscle Quality and Quantity Affect Prognosis after Neoadjuvant Chemotherapy with a Triple Regimen of Docetaxel/Cisplatin/5-FU in Patients with Esophageal Cancer
por: Ito, Nobuhito, et al.
Publicado: (2023)

Association of body mass index with 30-day mortality and red blood cell transfusions in open heart surgery
por: Räsänen, Jenni, et al.
Publicado: (2023)

Esophageal perforations: one is bad, two is worse
por: Price, Dustin, et al.
Publicado: (2019)

Concomitant preoperative airflow obstruction confers worse prognosis after trans-thoracic surgery for esophageal cancer
por: Lang, Ke, et al.
Publicado: (2023)

The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer
por: Nagao, Kazuhiro, et al.
Publicado: (2022)

Relation between skeletal muscle volume and prognosis in rectal cancer patients undergoing neoadjuvant therapy
por: De Nardi, Paola, et al.
Publicado: (2022)

Chemical profiles of birch and alder bark by ambient mass spectrometry
por: Räsänen, Riikka-Marjaana, et al.
Publicado: (2019)

Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
por: Rutten, Iris J.G., et al.
Publicado: (2016)

Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices
por: Sakai, Yoshiyuki, et al.
Publicado: (2017)

Skeletal muscle deficits are associated with worse exercise performance in pediatric pulmonary hypertension
por: Avitabile, Catherine M., et al.
Publicado: (2022)

Loss of skeletal muscle mass is not specific to type 2 diabetes
por: Zhou, Bo, et al.
Publicado: (2022)

Prediabetes is associated with loss of appendicular skeletal muscle mass and sarcopenia
por: Li, Shuying, et al.
Publicado: (2023)

Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2017)

Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma
por: Ollila, Hely, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3mredao340pfdvf5cqe8if2sk